hsa_circ_0000231 Promotes colorectal cancer cell growth through upregulation of CCND2 by IGF2BP3/miR-375 dual pathway.
hsa_circ_0000231 Promotes colorectal cancer cell growth through upregulation of CCND2 by IGF2BP3/miR-375 dual pathway.
复制标题
hsa_circ_0000231 通过 IGF2BP3/miR-375 双通路上调 CCND2 促进结直肠癌细胞生长
DOI:
10.1186/s12935-022-02455-8
复制
发表时间:
2022-01-15
影响因子:
5.8
通讯作者:
Shen Z
中科院分区:
文献类型:
--
作者:
Zhang W;Wang B;Lin Y;Yang Y;Zhang Z;Wang Q;Zhang H;Jiang K;Ye Y;Wang S;Shen Z
Circular RNAs (circRNAs) have emerged as vital regulators of the initiation and progression of diverse kinds of human cancers. In this study, we explored the role of hsa_circ_0000231 and its downstream pathway in CRC. The expression profile of circRNAs in 5 pairs of CRC tissues and adjacent normal tissues were analyzed by Microarray. Quantitative real-time PCR and in situ hybridization and Base Scope Assay were used to determine the level and prognostic values of hsa_circ_0000231. Then, functional experiments in vitro and in vivo were performed to investigate the effects of hsa_circ_0000231 on cell proliferation. Mechanistically, fluorescent in situ hybridization, dual luciferase reporter assay, RNA pull-down and RNA immunoprecipitation experiments were performed to confirm the interaction between hsa_circ_0000231 and IGF2BP3 or has_miR-375. We acquired data through circRNA microarray profiles, showing that the expression of hsa_circ_0000231 was upregulated in CRC primary tissues compared to adjacent normal tissues, which was indicated poor prognosis of patients with CRC. Functional analysis indicated that inhibition of hsa_circ_0000231 in CRC cell lines could suppress CRC cell proliferation as well as tumorigenesis in vitro and in vivo. The mechanistic analysis showed that hsa_circ_0000231 might, on the one hand, act as a competing endogenous RNA of miR-375 to promote cyclin D2 (CCND2) and, on the other hand, bind to the IGF2BP3 protein to prevent CCND2 degradation. The findings suggested that hsa_circ_0000231 facilitated CRC progression by sponging miR-375 or binding to IGF2BP3 to modulate CCND2, implying that hsa_circ_0000231 might be a potential new diagnostic and therapeutic biomarker of CRC. The online version contains supplementary material available at 10.1186/s12935-022-02455-8.
登录
查看更多内容
DOI:
10.1186/s13046-021-02074-7
发表时间:
2021-08-27
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Peng C;Tan Y;Yang P;Jin K;Zhang C;Peng W;Wang L;Zhou J;Chen R;Wang T;Jin C;Ji J;Feng Y;Tang J;Sun Y
通讯作者:
Sun Y
影响因子:
14.9
作者:
Li JH;Liu S;Zhou H;Qu LH;Yang JH
通讯作者:
Yang JH
影响因子:
29.4
作者:
Lai Y;Wang C;Civan JM;Palazzo JP;Ye Z;Hyslop T;Lin J;Myers RE;Li B;Jiang B;Sama A;Xing J;Yang H
通讯作者:
Yang H
DOI:
10.1007/978-981-13-1426-1_6
发表时间:
2018-01-01
期刊:
CIRCULAR RNAS: BIOGENESIS AND FUNCTIONS
影响因子:
--
作者:
Panda, Amaresh Chandra
通讯作者:
Panda, Amaresh Chandra
影响因子:
6.6
作者:
Qiu, Liman;Huang, Yanbing;Liu, Jingfeng
通讯作者:
Liu, Jingfeng